The problem gets bigger if we realise that only a marginal fraction of all R&D will lead to clinical changes. Paradoxically, we spend the least amount of research money on the largest bills. Of the total R&D expenses, only a very small part is being spent on healthcare services research - while 65% of all healthcare cost originate from the workforce and healthcare service system. While large investments are being made in pharma and R&D (globally $240 billion), most of the money goes to projects within the pharmaceutical companies and universities. He put to the audience that the main cause of this is the way research and innovation in healthcare is organised (with particular focus on the UK). Kieran Walshe’s excellent keynote address focused on the reasons for the notion of why the healthcare system seems to be designed to prevent (disruptive) innovation. Research and innovation systems in health and social care in the UK The Healthwise conference is a network meeting where the healthcare sector, academia and the policy world meet. The conference offered a diverse program with plenary presentations and parallel sessions of both scientists and professionals from practice.Ĭentre of Expertise Healthwise of the Faculty of Economics and Business annually organises a conference around current themes in the science and practice of Health (Care) Economics, Business, and Management.

Managers, professionals and researchers who work in the healthcare sector, science and policy world were cordially invited for this meeting. The theme of the conference was ‘Organising Healthcare Innovations’, with keynote speakers Kieran Walshe (Manchester Business School), Philippe Delespaul (Maastricht University) and Henk van der Wal (Institute for Defence and Partnerships Hospitals, Ministry of Defence). Centre of Expertise Healthwise of the University of Groningen organised its fourth annual Healthwise conference on Friday 4 November 2016.

Primary issues medical conferences 2016